Ventra. Validation Study of the Ventricle Feature Estimation and Classification Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Psychiatric Disorders and Other Degenerative Diseases
Social Science Research Network(2022)
摘要
Introduction Lateral ventricles are reliable and sensitive indicators of brain atrophy and disease progression in behavioral variant frontotemporal dementia (bvFTD). Here we validate our previously developed automated tool using ventricular features (known as VentRa) for the classification of bvFTD vs a mixed cohort of neurodegenerative, vascular, and psychiatric disorders from a clinically representative independent dataset.
Methods Lateral ventricles were segmented for 1110 subjects - 14 bvFTD, 30 other Frontotemporal Dementia (FTD), 70 Lewy Body Disease (LBD), 898 Alzheimer Disease (AD), 62 Vascular Brain Injury (VBI) and 36 Primary Psychiatric Disorder (PPD) from the publicly accessible National Alzheimer’s Coordinating Center dataset to assess the performance of VentRa.
Results Using ventricular features to discriminate bvFTD subjects from PPD, VentRa achieved an accuracy of 84%, 71% sensitivity and 89% specificity. VentRa was able to identify bvFTD from a mixed age-matched cohort (i.e., Other FTD, LBD, AD, VBI and PPD) and to correctly classify other disorders as ‘not compatible with bvFTD’ with a specificity of 83%. The specificity against each of the other individual cohorts were 80% for other FTD, 83% for LBD, 83% for AD and 84% for VBI.
Discussion VentRa is a robust and generalizable tool with potential usefulness for improving the diagnostic certainty of bvFTD, particularly for the differential diagnosis with PPD.
### Competing Interest Statement
Competing interests: Dr. Manera reports no disclosures Dr. Dadar reports no disclosures Dr. Collins is co-founder of True Positive Medical Devices. Dr. Ducharme receives salary funding from the Fonds de Recherche du Quebec - Sante. Dr. Ducharme is the co-founder of Arctic Fox AI.
### Funding Statement
This study did not receive any funding
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The data sample used for this study was obtained from the National Alzheimers Coordinating Centers Uniform Data Set (NACC). The NACC developed a database of standardized clinical research data obtained from past and present National Institute on Aging (NIA)-funded Alzheimers Disease Research Centers across the United States. NACC data collection has been previously described in Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006;20(4):210-6. doi: 10.1097/01.wad.0000213865.09806.92
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
All data produced in the present study are available upon reasonable request to the authors. Complete NACC dataset can be obtained upon request (https://naccdata.org/requesting-data/data-request-process)
* bvFTD
: Behavioral Variant Frontotemporal Dementia
PPD
: Primary Psychiatric Disorder
DBM
: deformation-based morphometry
CN
: normal controls
APR
: anteroposterior ratio
MCI
: mild cognitive impairment
AD
: Alzheimer’s dementia
FTD
: Frontotemporal Dementia
TVV
: total ventricular volume
LRFR
: left-right frontal ratio
LRTR
: left-right temporal ratio
NACC
: National Alzheimer’s Coordinating Center dataset
LBD
: Lewy Body Disease
VBI
: Vascular Brain Injury
T1w
: T1-weighted (T1w)
TFE
: Turbo Field Echo
FSE
: Fast spin echo
FSPGR
: fast spoiled gradient-echo
MPRAGE
: Magnetization Prepared - RApid Gradient Echo
MMSE
: Mini-Mental Status Examination
CDR
: Clinical Dementia Rating
CDR-SB
: Clinical Dementia Rating-Sum of Boxes
LR
: Likelihood ratios
FN
: False negatives
TP
: True positives
FP
: False positives
ROI
: Region of Interest
更多查看译文
关键词
behavioral variant frontotemporal dementia,ventricle feature estimation,other degenerative diseases
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要